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Intercellular communication is pivotal in optimizing and synchronizing cellular responses
to keep homeostasis and to respond adequately to external stimuli. In the central nervous
system (CNS), glutamatergic and GABAergic signals are postulated to be dependent on
the glutamate/GABA-glutamine cycle for vesicular loading of neurotransmitters, for inacti-
vating the signal and for the replenishment of the neurotransmitters. Islets of Langerhans
release the hormones insulin and glucagon, but share similarities with CNS cells in for
example transcriptional control of development and differentiation, and chromatin methyla-
tion. Interestingly, CNS proteins involved in secretion of the neurotransmitters and emitting
their responses as well as the regulation of these processes, are also found in islet cells.
Moreover, high levels of glutamate, GABA, and glutamine and their respective vesicular and
plasma membrane transporters have been shown in the islet cells and there is emerging
support for these amino acids and their transporters playing important roles in the matu-
ration and secretion of insulin and glucagon. In this review, we will discuss the feasibility
of recent data in the field in relation to the biophysical properties of the transporters (Slc1,
Slc17, Slc32, and Slc38) and physiology of hormone secretion in islets of Langerhans.
Keywords: GABA, glutamate, glutamine, insulin, SAT2, Slc38a2, Slc38a3, SN1
INTRODUCTION
The endocrine cells of the pancreas and the cells of nervous sys-
tem have different functions but also reveal interesting similarities.
Islet cells of Langerhans secrete insulin and glucagon and are
considered to be necessary for maintaining glucose homeostasis.
However, neurons may also release insulin, and compelling evi-
dence have been provided for a brain-centered glucoregulatory
system that work in concert with the islet cells to regulate plasma
levels of glucose (1–3). Interestingly, recent advances in the field
reveal mechanistic similarities in the regulation of insulin and
glucagon secretion in the islets as compared to neurotransmitter
release. Amino acids, which play pivotal roles in fast neuronal sig-
naling, have also been proposed to act as signaling molecules in
the islets of Langerhans (4–7). This is consistent with the detec-
tion of significant changes in plasma glutamine concentrations in
newly diagnosed diabetic patients (8) indicating that dysfunctional
amino acid metabolism, signaling, and/or amino acid transporter
function may precede and/or augment development of diabetes.
In this review, we will discuss the significance of glutamate, GABA,
and glutamine and their transporters in the regulation of insulin
and glucagon secretion in the pancreas.
AMINO ACID TRANSPORTERS AND NEURONAL SIGNALING
Classical neuronal signaling is a form of paracrine signaling where
a neurotransmitter is released at the synapse from a neuron and
the message is conveyed by activation of specific receptors on
the surface of an adjacent neuron. Several amino acids play fun-
damental roles in synaptic transmission. Glutamate and GABA
are the main fast excitatory and inhibitory neurotransmitters,
respectively. After their release, the signal is partly inactivated by
transport of the released neurotransmitter into astroglial cells and
conversion to glutamine catalyzed by glutamine synthetase (GS)
(9, 10). Glutamine may then be released from astroglial processes
and shuttled back to neurons for regeneration of the transmit-
ters by the neuronal phosphate-activated glutaminase (PAG) (11,
12). Existence of such a cycle, known as the glutamate/GABA-
glutamine (GGG) cycle, is bolstered by the demonstration of
glutamate and GABA transporters on synaptic vesicles and on
perisynaptic astroglial plasma membranes (13–17), and by the
characterization of the Slc38 family of amino acid (glutamine)
transporters (18–20). We have demonstrated that the Slc38 fam-
ily members SN1 (Slc38a3) and SN2 (Slc38a5) release glutamine
from the astrocytes (18, 21, 22), while SAT2 (Slc38a2) imports
glutamine into glutamatergic neurons and maintains neurotrans-
mitter pools of glutamate involved in retrograde signaling (23).
The Slc38 family member SAT1 (Slc38a1) is selectively localized in
inhibitory neurons supporting uptake of glutamine for GABA for-
mation (19, 24). Consistent with a role of SAT1 in the GGG cycle,
the SAT inhibitor MeAIB reduces GABAergic inhibitory synaptic
transmission (25, 26). However, the presence of these transporters
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also in peripheral organs suggests important roles in cell-specific
metabolism and/or in non-neuronal signaling (27–29).
THE ENDOCRINE CELLS OF THE ISLETS OF LANGERHANS HARBOR
PROTEINS INVOLVED IN CLASSICAL NEURONAL SIGNALING
The endocrine cells of the pancreas share many characteristics with
the cells of the central nervous system (CNS). The two tissues share
a similar transcription program (30) and have extensive similari-
ties in global mRNA expression and chromatin methylation (31).
In addition, transcription factors like Pax6 and Nkx6.1 are impor-
tant for development and differentiation of both neurons and islet
cells (32–34).
The endocrine islet cells also contain most of the components
involved in synaptic transmission in the CNS. In addition to
the hormone loaded secretory granules (SGs), islet cells contain
synaptic-like microvesicles (SLMVs) resembling synaptic vesicles
found in nerve terminals (35, 36). The exocytosis of SGs and
SLMVs also share many similarities with the exocytosis of synap-
tic vesicles. As in the CNS, exocytosis is dependent on the opening
of voltage-dependent Ca2+ channels (37, 38), and on the com-
plex assembly of SNARE proteins including SNAP25 and syntaxin
coupled to the vesicle and to the target membrane (39). Further-
more, exocytosis and hormone secretion is in both regulated by
myotrophin, and the same miRNA, miR-375, regulates transla-
tion of its gene in both tissues (40). In addition, the biogenesis
of SLMVs in β-cells is dependent on the same adaptor protein
complex as in GABAergic neurons (41).
There is co-release of glucagon and glutamate fromα-cells (42),
and SLMVs of β-cells contain high levels of glutamate (43). In
β-cells, glutamate activation of AMPA and kainate receptors stim-
ulates Ca2+ influx and insulin secretion (44, 45), whereas mGluR
stimulation, both inhibit and stimulate insulin secretion depend-
ing on the concentration of glucose (46, 47). In addition, glutamate
stimulates GABA release from SLMVs in β-cells independently of
insulin release (48). In α-cells, glutamate inhibits glucagon secre-
tion. Thus, glutamate is involved in both paracrine and autocrine
regulation of glucagon and insulin.
When it comes to GABAergic signaling, GABAA receptor acti-
vation is important for β-cell autocrine feedback (49), and it
reduces glucagon secretion from α-cells (50, 51). Furthermore,
the key enzymes involved in the metabolism of the neurotransmit-
ters glutamate and GABA, e.g., PAG, glutamic acid decarboxylase
(GAD), and GS, are all present in islet cells (4, 52, 53). In fact, islet
β-cells contain GABA and GAD at the same levels as GABAergic
neurons (54, 55), and β-cells have the highest GABA concentration
outside the CNS.
GLUCOSE AND AMINO ACIDS IN THE REGULATION OF INSULIN
SECRETION
The main triggering signal for insulin release from β-cells is ele-
vated plasma glucose levels. When plasma glucose levels rise post-
prandially, facilitated transport by the low affinity glucose trans-
porter GLUT2 (K m= 15–20 mM), the primary glucose trans-
porter present on β-cells (56), is initiated (Figure 1). In β-cells,
glucose is metabolized through the TCA cycle to yield ATP, the
main stimulator of insulin secretion (37). ATP acts by closing
potassium channels
(
K+ATP
)
which leads to depolarization of the
β-cell (37). Exocytosis of insulin containing SGs occurs when Ca2+
levels rise after opening of voltage-gated Ca2+-channels (37, 38).
Many amplifying signals modify islet secretion (57). There is
support for amino acids influencing the endocrine function of the
pancreas (4–6), and in particular glutamate, GABA, and glutamine
are postulated to play a role in the regulation of hormone secre-
tion (4, 7). Deletion of glutamate dehydrogenase (GDH), which
catalyzes the conversion between glutamate and the TCA cycle
intermediate α-ketoglutarate, decreases glucose-induced insulin
secretion by approximately 40% (58). In addition, glutamine’s
ability to evoke insulin release is decreased in isolated islets from
GDH knockouts (59). Furthermore, the very close proximity
between the different cell types in human islets facilitates flux
of substrates and paracrine signaling for the orchestration of islet
secretion (Figure 1) (60, 61). Thus, there are compelling evidence
for glutamate, GABA, and glutamine being involved in regulating
islet hormone secretion.
AMINO ACID TRANSPORTERS IN ISLET SECRETION
As described above, glutamate and GABA, their specific receptors
and effects, as well as the enzymes involved in their metabolism
have all been shown in the islet. However, the mechanisms involved
in the transport of amino acids across plasma and vesicle mem-
branes and mode of action in the islet cells are poorly understood.
Interestingly, recent advances in the characterization of amino
acid transporters in the islets reveal peculiar insight into novel
mechanisms for signaling in the islets.
VESICULAR GLUTAMATE AND GABA TRANSPORTERS ARE LOCALIZED
ON SLMVs AS WELL AS SGs IN ISLET CELLS
Glutamate is transported into synaptic vesicles by the vesicu-
lar glutamate transporters (VGLUT1-3) of the Slc17 family (62),
whereas VGAT (Slc32) transports the inhibitory neurotransmit-
ters GABA and glycine (63, 64). In the CNS, the VGLUTs and
VGAT may be localized on different subsets of synaptic vesicles or
co-localized on the same vesicles (65–68). This differential local-
ization of vesicular transporters allows for co-release or differential
release of transmitters, as well as concerted action to increase
packaging.
Islet cells express both VGLUTs and VGAT (Figure 1). In α-
cells, VGLUT1 and VGLUT2 are found on glucagon containing
SGs (43, 69), supporting the finding that there is co-release of
glucagon and glutamate from α-cells (42). On the SLMVs of the
α-cells, there is expression of the 57-kDa isoform of VGAT found
in the CNS (55, 70–72), but in addition a novel 52.5 kDa isoform
is found on the SGs (72). The expression levels of the 52.5-kDa
VGAT isoform increase with increasing glucose levels, opposite to
the regulation of the transcription and activity of VGLUT1 and
VGLUT2 which is down-regulated by increasing glucose levels in
islet cell cultures (73). Thus, granular loading of glutamate, GABA,
and glycine changes with changing glycemic conditions, allowing
for fine-tuning of hormone secretion.
In the β-cells, VGLUT3 is found on both SGs and SLMVs
(Figure 1A) (43). However, the SGs contain little glutamate (43),
and direct stimulation of granule secretion with sulfonylurea
tolbutamide, which closes ATP-sensitive potassium channels, does
not lead to glutamate release from β-cells (74), questioning the
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FIGURE 1 | Amino acids in pancreatic endocrine signaling and insulin
maturation. (A) Amino acids are shuttled between cells and intracellular
compartments and are involved in autocrine and paracrine signaling in the
pancreatic islets of Langerhans. High levels of glucose (Gluc) are carried by
the blood flow to the islet β-cells where glucose is accumulated by a glucose
transporter (GLUT2). Through glycolysis, glucose is catabolized to pyruvate
(Pyr) which is transported into mitochondria for oxidative phosphorylation.
The product, ATP, inhibits K+-channels. As a result, β-cells are depolarized and
this stimulates fusion of insulin containing secretory granules (SGs) with the
plasma membrane. Glutamine carried by blood can be accumulated inside
β-cells by SN1 on their plasma membrane. Glutamine may be converted to
glutamate by phosphate-activated glutaminase (PAG) and enter the TCA cycle
inside mitochondria (1) to produce ATP which may regulate K+-channels in
the same way as glucose. Alternatively, glutamate may be translocated into
synaptic-like microvesicles (SLMVs) (3) or insulin containing SG (4). Finally,
glutamate may be metabolized to GABA (2) by glutamic acid decarboxylase
(GAD) and accumulated inside SLMVs for secretion. In α-cells, SAT2
accumulates high levels of glutamine which may be metabolized to
glutamate and/or GABA by PAG and GAD, respectively. The vesicular
glutamate transporters (VGLUT) 1 and 2 and VGAT then transport glutamate
(1) and GABA (2) into SLMVs and glucagon containing SG for exocytotic
release. (B) VGLUT3-mediated transport of glutamate into SGs, followed by
GLT/EAAT2-mediated transport out, contributes to maturation of insulin. A
vacuolar (V)-ATPase generates a high electrochemical gradient for H+. Flux of
H+ through VGLUT3 and down its electrochemical gradient energizes
transport of glutamate (Glu−) into SGs. Subsequently, the glutamate
transporter GLT/EAAT2 translocates glutamate out of the SG, and this
transport is coupled to 3 Na+ and 1 H+ transport in symport and 1 K+ in
antiport. The concerted action of VGLUT3 and GLT/EAAT2 results in a net
movement of positive charge out of the SG. This counteracts inhibition of the
V-ATPase and augments accumulation of H+ inside SG. Such acidification
stimulates conversion of pro-insulin to insulin. The chloride channel CLC-3
also resides on the membranes of SG. Transport of Cl− down its
electrochemical gradient (into SG lumen) by CLC-3 also counteracts inhibition
of the V-ATPase and increases the luminal acidification which stimulates
maturation of insulin.
role of SG release of glutamate as important for signaling. Unlike
β-cell SGs, SLMVs accumulate glutamate and express high levels
of VGLUT3 (43). It has been hypothesized that the main function
of SLMV exocytosis is to supply the plasma membrane with the
proteins and lipids necessary to withstand the stress from sub-
stances like Zn2+ secreted together with insulin (75). However,
the presence of VGLUT3 on and glutamate in SLMVs might indi-
cate that glutamate release from β-cells participates in feedback
mechanisms regulating insulin secretion. This is supported by the
fact that exocytosis of SLMVs and SGs is differentially regulated
through two cAMP-dependent pathways (75). β-cells also express
the 57-kDa isoform of VGAT on SLMVs (55, 71, 72), which prob-
ably primarily supports GABA release, as β-cells contain much
higher levels of GABA compared to glycine (55).
Thus, both islet SGs and SLMVs have the machinery necessary
to load them with glutamate and/or GABA and glycine, which can
then be released in an exocytotic manner.
PLASMAMEMBRANE GLUTAMATE TRANSPORTERS MAY TERMINATE
FAST TRANSMISSION AS WELL AS CONTRIBUTE TO A NOVEL
MECHANISM FOR THE MATURATION OF SGs
Na+-dependent glutamate transport across the cell membrane in
islet cells (76), probably facilitated by the glutamate transporter
GLT/EAAT2 (Slc1) expressed on the plasma membrane of pancre-
atic β-cells (77), can terminate glutamate signaling (Figure 1A). In
fact, glutamate transport by EAAT2 prevents glutamate induced
excitotoxicity as down-regulation of EAAT2 lead to increased
β-cell death, whereas up-regulation increased β-cell survival (77).
EAAT2 has also been shown to be strongly expressed on the
membrane of SGs in β-cells (43), and co-localizes with both chro-
mogranin, a neuroendocrine secretory protein in granules, and
insulin in β-cells (77). As discussed above, the SGs also express
VGLUT3, but there is very little concomitant release of glutamate
and insulin (74) and glutamate levels inside SGs are insignificant
(43). The presence of both of these transporters in the β-cells raises
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the possibility of alternative mechanisms through which glutamate
can act as an intracellular signaling molecule modulating the
release of insulin.
Gammelsæter and co-workers postulated that glutamate trans-
port might participate in the maturation of insulin in the
SGs, and thus the regulation of insulin release (43). SGs con-
tain a vesicular H+-ATPase which pumps protons into the SGs
(Figure 1B). Uptake of negatively charged glutamate by VGLUT3
sets up a counter-charge movement which decreases the gran-
ular membrane polarization allowing sustained transport by the
H+-ATPase. If glutamate leaves the SGs through EAAT2, three pos-
itively charged sodium ions and a proton will be exported, while
one potassium ion will enter the SG. Thus, there will be a net export
of positive charge, further counteracting inhibition of the H+-
ATPase, allowing for further acidification of the SG. Acidification
is crucial for the conversion of pro-insulin to active insulin (78, 79),
and it is thought to be important for the exocytotic process (79).
Interestingly, perturbation of the granular acidification by genetic
deletion of the chloride channel ClC-3, which resides on the SGs
(Figure 1B), also results in abolished insulin release (80). Chlo-
ride ions also regulate or penetrate VGLUTs and VGAT (81, 82),
and may acidify SG in multiple ways. Altogether, these data sug-
gest that VGLUT3 probably works in consortium with EAAT2 to
acidify the SGs through glutamate import and subsequent export,
which further regulates the level of insulin released upon glucose
stimulation.
MEMBERS OF THE Slc38 FAMILY OF AMINO ACID TRANSPORTERS
MIGHT BOTH SUPPLY GLUTAMINE FOR THE FORMATION OF
GLUTAMATE AND GABA AND CONTRIBUTE TO PLASMAMEMBRANE
DEPOLARIZATION IN THE ISLETS OF LANGERHANS
The islets of Langerhans express transcripts for several members
of the Slc38 gene family (Figures 1A and 2) (83). Immunofluo-
rescence co-labeling with antibodies against SN1 and SAT2 with
specific markers for the different cell populations of the islets
showed SN1 at the plasma membrane of β-cells, whereas SAT2
was found on the membrane of α-cells. This distribution resem-
bles the complementary expression pattern of SAT2 and SN1 in the
CNS, where SN1 and SAT2 transport glutamine from astrocytes to
glutamatergic neurons for the replenishment of glutamate (23).
SN1 translocates glutamine coupled to a symport of Na+ (18).
In addition, it is sensitive to pH, and SN1 both transports pro-
tons coupled to the transport of glutamine and allows for flux
of protons not stoichiometrically dependent on the movement
of substrate (21, 84, 85). Under most physiological conditions,
the electroneutral SN1 may therefore transport glutamine bidi-
rectionally (18, 21, 84–87). SN1 at the membrane of β-cells might
therefore accumulate glutamine for glutamate and GABA synthesis
(Figures 1A and 2), but at different feeding status it may contribute
to the release of glutamine (Figure 2), as discussed below.
Glutamine has been shown to have a profound effect on insulin
secretion (4–6). Increased levels of glutamate and GABA in β-cells
from replenishment by glutamine are not sufficient to explain this
strong effect on secretion. It is therefore likely that glutamine con-
tributes to the regulation of insulin secretion through additional
mechanisms. First, glutamine taken up by SN1 might stimulate
insulin secretion through the conversion of glutamine to glutamate
by PAG (Figure 1A), which is present in β-cells (53). This is in
agreement with earlier findings showing conversion of glutamine
to glutamate in islet cells (88, 89). In the β-cell, glutamate can then
enter the TCA cycle through the action of GDH, and stimulate
insulin secretion in the same K+ATP-dependent way as glucose (53).
This is supported by the fact that, in isolated islets from GDH
knockouts there is an abrogation of insulin release evoked by glu-
tamine (59). Alternatively, glutamate flux through VGLUT3 and
EAAT2 on SGs might contribute to the maturation of insulin, as
described above (Figure 1B). Glutamine transport by SN1 can
also contribute to the depolarization of the membrane of β-cells.
As already mentioned SN1 is sodium dependent and exhibits a
channel-like activity, for e.g., protons, inducing inward currents
(18, 21, 85). Due to these characteristics, SN1 can have a depo-
larizing effect upon transport of glutamine (21). The potassium
channel K+ATP is responsible for the depolarization initiated insulin
release in response to glucose. In knockout mice with a loss of
function mutation of the K+ATP, insulin secretion can be triggered
by amino acids (4). This effect decreased 60% if glutamine was
omitted, which was suggested to be due to the depolarizing effect
of glutamine transport into the cell (4), and the conveyer may
well be SN1 (83). Thus, glutamine uptake by SN1 due to elevated
serum levels of glutamine may not only stimulate insulin secre-
tion through conversion to glutamate, but also by amplifying the
depolarization of the plasma membrane.
Lack of coupling to proton translocation enables the SATs to
utilize both the electrical and the chemical gradients of sodium,
creating higher glutamine concentration gradients compared to
SN1 (19, 23, 90). In addition, SAT2 has higher affinity for gluta-
mine than SN1 (90). According to our findings, SAT2 is expressed
on α-cells (Figures 1A and 2) (83). In α-cells, glutamate is exo-
cytosed together with glucagon when blood glucose levels are low
(42). As SAT2 is able to create a large concentration gradient of
glutamine across the membrane, SAT2 might therefore ensure a
constant supply of glutamine for the production of glutamate.
Interestingly, when the interprandial serum levels of glutamine
are low, flux reversal of SN1 might assure substrate for transport
by SAT2 (Figure 2). Since system A transport depolarizes cells (19,
90), its activity might also stimulate glucagon secretion in a similar
manner to the postulated role of SN1 in β-cell depolarization.
All in all, as SN1 changes direction of transport at glutamine
concentrations well within physiological fluctuations in amino
acid content of the blood (18), SN1 might be a convenient con-
veyer of plasma amino acid level stimuli for islet cell secretion. We
have therefore proposed that SN1 works as a sensor of nutritional
status (83). When the blood glutamine concentration is high it
may mediate uptake of glutamine in β-cells. However, when blood
glutamine concentration decreases between meals it may medi-
ate release from β-cells. This will promote the ability of SAT2 to
import glutamine into α-cells and thus stimulate glucagon secre-
tion (Figure 2). Furthermore, insulin has been shown to regulate
SN1 expression and function (28), allowing for possible additional
feedback mechanisms.
CONCLUSION
The main components of synaptic transmission are present in
the islet cells implicating similarities in signaling pathways. This
Frontiers in Endocrinology | Cellular Endocrinology December 2013 | Volume 4 | Article 199 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Jenstad and Chaudhry Glutamate and glutamine transporters in islet secretion
FIGURE 2 | Direction of glutamine transport in the islet cells of
Langerhans is differential and dependent on prandial status.
(A) Postprandially, blood supplied to the islets is enriched in glucose and
amino acids such as glutamine (Gln). Gln is captured by SN1 and metabolized
in β-cells to stimulate insulin secretion as described (Figure 1). As a result,
blood glucose levels are reduced. (B) Interprandially, blood supplied to the
islets has lower concentrations of Gln and glucose. Gln now preferentially
activates SAT2 on α-cells due to its higher affinity for Gln. In addition, changes
in the Gln gradient across the cell membrane of β-cells may stimulate SN1 to
release glutamine which can then be taken up by adjacent α-cells. Enhanced
Gln metabolism in α-cells stimulates secretion of glucagon which raises blood
glucose levels.
notion is further reinforced by the fact that human neural prog-
enitor cells may be differentiated to produce insulin (1). In the
CNS, synaptic transmission is based on a tripartite synapse where
the perisynaptic astroglial cells actively participate in fine-tuning
and termination of the signal and in supplying precursors for
the neurotransmitters. An analog to the tripartite synapse does
not exist in the islets of Langerhans. However, secretion by the
different islet cells is regulated by both paracrine and autocrine
signaling, which again depends on glutamate and GABA. More-
over, the amino acid transporters involved in the GGG cycle in
the CNS do have the corresponding and necessary localizations to
support glutamine-mediated synthesis of glutamate and GABA,
their exocytotic release and termination of the signal in the islets
of Langerhans. Depolarization of the plasma membrane due to
inward transport by SN1 upon elevated plasma glutamine con-
centration and/or its metabolism to glutamate and ATP might
be important regulators of insulin secretion after protein rich
meals. Similarly, glutamine from plasma or from β-cells upon
reversed action of SN1 may activate SAT2 on α-cells (Figure 2).
Such glutamine transport may depolarizeα-cells and/or glutamine
may be metabolized to glutamate to regulate glucagon secretion.
This resembles the situation in the CNS where glutamine uptake
through SAT1 depolarizes the nerve terminal and regulate trans-
mitter release (19). The co-localization of EAAT2 and VGLUT3 on
insulin containing SGs supports a cell-specific flux of glutamate
through the granules, which may facilitate the acidification nec-
essary for insulin maturation prior to secretion. Thus, there are
several striking similarities, but there are also important differ-
ences in the functional roles of the amino acid transporters in
these two tissues. Altogether, our data suggest that in addition to
insulin secretion in the islets of Langerhans and the brain-centered
glucoregulatory system (3), amino acid metabolism and amino
acid transporters might also be potential therapeutic targets in
diabetes.
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